A woman stands at a pharmacy counter with three bags in front of her and a total she wasn't expecting. She doesn't ask about it. She does something quieter and more common: she picks up the bag she can live without for a week and slides it back across the counter. "Just the insulin today," she says. Nobody at the counter blinks. They've seen it before.

Here is the uncomfortable part. When people with diabetes skip something because of cost, it's often not the thing the headlines are about. It's a line item they didn't know was the problem, buried in a stack of five or six.

Diabetes isn't one prescription. It's a stack.

When someone says "my diabetes medication costs too much," they usually mean a bundle. A pill like metformin. Maybe a second oral drug. Possibly insulin, pen needles, test strips, lancets, a glucose meter or sensor. Often a statin and a blood pressure pill too, because diabetes rarely travels alone.

Each of those has its own price logic. Metformin is one of the oldest and most widely made generics in the country, and the drug's national average acquisition cost, which is what CMS tracks through its NADAC survey of pharmacy purchase prices, is very low. Insulin follows different rules: patents, device pens, and a pricing history that has been genuinely contentious. Test strips and sensors are supplies, not drugs, and aren't priced like either.

So the total at the counter is a blend of very cheap things and very expensive things. Looking at the total tells you almost nothing about which is which.

What researchers call cost-related nonadherence

There's a real term for what that woman did: cost-related medication nonadherence. It describes people who skip doses, split pills, delay refills, or don't fill at all because of price. It has been studied extensively in chronic conditions, and diabetes is one of the conditions where it matters most, because the consequences of undertreatment build quietly over years and sometimes arrive suddenly.

What the research on this consistently suggests is that people don't make these choices carelessly. They triage. And triage works badly when you can't see the individual prices.

Why the total hides the real problem

There's a psychological piece here, and it's worth naming. Behavioral scientists Sendhil Mullainathan and Eldar Shafir argued, in their work on scarcity, that having too little of something, money included, consumes mental bandwidth. When you're doing arithmetic under pressure, your attention narrows to the immediate shortfall. You stop optimizing and start surviving.

At a pharmacy counter, that looks like this: you hear a single number, your attention locks onto it, and you decide by feel. You cut whatever seems least urgent. Metformin, a pill you take without noticing any effect, feels skippable. Insulin and the test strips feel essential. So the cheapest item in the bag gets cut first, even though skipping it saves you almost nothing and costs you the most.

That's a quiet irony. The decision feels like economy, but it's often the reverse: a tiny savings paid for with a large health risk. Triage only works when the numbers underneath it are visible.

Separate the stack into its parts

The single most useful thing you can do is stop treating your diabetes care as one price. Break it apart and ask three different questions about three different kinds of item.

Generic oral medications. Metformin and several older oral drugs are typically very inexpensive, and prices can vary widely between pharmacies for the same bottle. If you're paying a lot for one of these, it's worth checking whether you're being charged an inflated cash price, or whether your insurance copay is higher than the cash price would be. That second situation is more common than people expect.

Insulin. The landscape here has shifted. Medicare Part D now caps monthly out-of-pocket costs for covered insulin at $35. Several major manufacturers also introduced $35 monthly programs for people who are uninsured or commercially insured. Terms and eligibility change, so check the manufacturer's current page rather than trusting anyone's memory, including mine. Also ask your prescriber whether an older human insulin, which can be priced much lower, is clinically reasonable for you. That is a medical call, not a money-only one.

Supplies. Strips, lancets, and sensors often sit in a different pricing world entirely. Ask the pharmacist which meter brands have cheaper strips, because the meter itself is often inexpensive and the strips are where the cost lives. Your clinician can tell you how often you actually need to test, which varies a lot by regimen.

The fair price tells you where the real money is

Once you separate the stack, a useful pattern appears. For the generic pills, you can compare what you're charged against a national benchmark. The NADAC figure is what pharmacies pay on average to acquire the drug, so a cash price that's many multiples of it is a signal to shop around. It's not a price you'll always get, since pharmacies add a dispensing fee and margin, but it's an honest anchor.

For insulin and supplies, the benchmark matters less than the program you qualify for. The question there isn't "is this fair?" but "is there a capped option I haven't been offered?"

Either way, you've turned a vague dread into two or three answerable questions.

Your next moves

  • Write out your full stack tonight. List every drug, device, and supply you use for diabetes and anything that goes with it, with the quantity per fill. You can't triage what you haven't itemized.
  • Ask the pharmacist for line-by-line prices, not a total. Say: "Can you give me the cash price for each item separately?" Then note which one is the actual expensive line.
  • Call two other pharmacies about only your generic pills. Ask for the cash price for the exact drug, strength, and quantity. Same bottle, often different numbers.
  • Check your insulin options this week. Look up the current manufacturer savings program for your specific insulin, and if you're on Medicare Part D, confirm your plan applies the $35 cap.
  • Bring one question to your next appointment: "Which of these could be swapped for a cheaper equivalent, and which should I never skip?" Your prescriber can tell you which items are safe to substitute and which carry real risk if interrupted.
  • Never quietly drop a dose to stretch a bottle. If money is forcing a choice, call your prescriber's office first. They can often adjust the plan, supply samples, or point you to assistance.

Where SnapRx fits

The hardest moment in all of this is standing at the counter with one number and no way to tell which part of it is the problem. SnapRx, from SnapRx, is built for the step before that moment: you snap the label on a prescription, see the national-average price benchmark drawn from CMS NADAC data, and find nearby pharmacies to call. For the generic pills in your stack, it gives you the typical number so a quote either looks right or looks off before you pay. If that would help, you can try it at snaprx.lumenlabs.works, and if not, the list above works just as well on paper.